Holen Sie sich die Stockscreener-App
6.48
2.53%
0.16
Handel nachbörslich:
6.45
-0.03
-0.46%
Schlusskurs vom Vortag:
$6.32
Offen:
$6.21
24-Stunden-Volumen:
8,992
Relative Volume:
0.70
Marktkapitalisierung:
$63.71M
Einnahmen:
$71.19M
Nettoeinkommen (Verlust:
$-59.54M
KGV:
-1.1159
EPS:
-5.8068
Netto-Cashflow:
$-18.58M
1W Leistung:
-2.99%
1M Leistung:
-8.22%
6M Leistung:
-2.14%
1J Leistung:
-24.07%
1-Tages-Spanne:
$6.21
$6.80
1-Wochen-Bereich:
$6.16
$7.29
52-Wochen-Spanne:
$2.62
$8.99
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Firmenname
Burning Rock Biotech Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BNR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
6.48 | 63.71M | 71.19M | -59.54M | -18.58M | -5.8068 |
|
TMO
Thermo Fisher Scientific Inc
|
571.51 | 218.67B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
206.78 | 148.44B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
145.26 | 41.57B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
459.78 | 37.56B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
208.26 | 36.56B | 15.32B | 1.41B | 1.96B | 7.62 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Aktie (BNR) Neueste Nachrichten
Burning Rock Announces Results of 2024 Annual General Meeting - Marketscreener.com
Burning Rock Announces Results of 2024 Annual General Meeting - GlobeNewswire Inc.
Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Canada Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech CFO Leo Li resigns - Investing.com
Burning Rock Biotech Limited Announces the Resignation of Leo Li as Chief Financial Officer - Marketscreener.com
Brazil Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - US-China Institute
Transcript : Burning Rock Biotech Limited, Q4 2021 Earnings Call, Mar 22, 2022 - Marketscreener.com
Burning Rock Biotech LtdADR Shares Approach 52-Week LowMarket Mover - Nasdaq
Burning Rock (BNR) in Focus: Stock Moves 5.4% Higher - Yahoo Finance
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
BioLine Rx (NASDAQ:BLRX) Stock Quotes, Forecast and News Summary - Benzinga
Citi Appointed Depositary Bank for Burning Rock Biotech Limited’s Sponsored ADR Program - Business Wire
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga
Finanzdaten der Burning Rock Biotech Ltd Adr-Aktie (BNR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):